We are live on
!
Find out more
BCM
Billings Capital Management Portfolio holdings
AUM
$79.3M
1-Year Est. Return
37.63%
This Fund
S&P 500
This Quarter
Est. Return
+9.99%
1 Year Est. Return
+37.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$6.74M
(-5.7%)
Cap. Flow
-$16.2M
Cap. Flow
% of AUM
-14.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
8
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$7.19M |
| 2 |
Bank of America
BAC
|
+$4.58M |
| 3 |
Credit Acceptance
CACC
|
+$796K |
| 4 |
Synchrony
SYF
|
+$728K |
| 5 |
MasTec
MTZ
|
+$662K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.12% |
| 2 | Financials | 36.18% |
| 3 | Industrials | 26.7% |
| 4 | Healthcare | 0% |
Similar funds
DC
LMAM
MTM
SCC
CG1
VIA
ST
BBCM
Billings Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Billings Capital Management held 10 positions worth $112M, down 5.7% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Billings Capital Management withdrew a net $16.2M in Q2 2019, closing 2 positions and reducing 8 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $7.19M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 35% a quarter earlier, followed by Financials and Industrials.
- Billings Capital Management's biggest Q2 2019 reduction was Credit Acceptance, cutting an estimated $796K.
- Billings Capital Management fully exited Syneos Health, Inc. Class A Common Stock in Q2 2019, selling an estimated $7.19M.
- Billings Capital Management's ten largest holdings make up 100% of its $112M portfolio in Q2 2019.
- Billings Capital Management opened 0 new positions and closed 2 in Q2 2019.
- Billings Capital Management's portfolio value fell 5.7% quarter-over-quarter to $112M.
Based on Billings Capital Management's 13F filing for Q2 2019, filed 19 Aug 2019.